עקוב אחר
André J scheen
André J scheen
CHU Liège, Liège Université
כתובת אימייל מאומתת בדומיין chuliege.be
כותרת
צוטט על ידי
צוטט על ידי
שנה
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a …
JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann, ...
The Lancet 366 (9493), 1279-1289, 2005
51892005
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and …
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal 41 (2), 255-323, 2020
42052020
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular …
Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ...
European heart journal 34 (39), 3035-3087, 2013
23432013
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
N Esser, S Legrand-Poels, J Piette, AJ Scheen, N Paquot
Diabetes research and clinical practice 105 (2), 141-150, 2014
21552014
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
LF Van Gaal, AM Rissanen, AJ Scheen, O Ziegler, S Rössner
The Lancet 365 (9468), 1389-1397, 2005
20312005
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16142012
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13162018
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
AJ Scheen, N Finer, P Hollander, MD Jensen, LF Van Gaal
The Lancet 368 (9548), 1660-1672, 2006
9442006
Clinical pharmacokinetics of metformin
AJ Scheen
Clinical pharmacokinetics 30, 359-371, 1996
8131996
Roles of circadian rhythmicity and sleep in human glucose regulation
E Van Cauter, KS Polonsky, AJ Scheen
Endocrine reviews 18 (5), 716-738, 1997
7231997
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ...
The Lancet 389 (10077), 1399-1409, 2017
6922017
Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty
FH Luyckx, C Desaive, A Thiry, W Dewe, AJ Scheen, JE Gielen, ...
International journal of obesity 22 (3), 222-226, 1998
6401998
Pharmacodynamics, efficacy and safety of sodium–glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus
AJ Scheen
Drugs 75, 33-59, 2015
6052015
Effect of nateglinide on the incidence of diabetes and cardiovascular events
NAVIGATOR Study Group
New England Journal of Medicine 362 (16), 1463-1476, 2010
5762010
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication
MA De Hert, R van Winkel, D Van Eyck, L Hanssens, M Wampers, ...
Schizophrenia research 83 (1), 87-93, 2006
4972006
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss
FH Luyckx, PJ Lefebvre, AJ Scheen
Diabetes and Metabolism 26 (2), 98-106, 2000
4912000
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system
AJ Scheen
Drugs 64, 2537-2565, 2004
4402004
Pathophysiology of type 2 diabetes
AJ Scheen
Acta Clinica Belgica 58 (6), 335-341, 2003
4252003
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 1. A meta-analysis of randomised clinical trials
AJ Scheen
Diabetes & metabolism 30 (6), 487-496, 2004
4072004
Magnesium and glucose homeostasis
G Paolisso, A Scheen, F d'Onofrio, P Lefebvre
Diabetologia 33, 511-514, 1990
4051990
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20